Literature DB >> 20678372

Embolisation of Ruptured Cerebral Aneurysms with Interlocking Detachable Coils in Acute Stage. Acute IDC Embolisation for Ruptured Aneurysms.

H Manabe1, S Fujita, T Hatayama, H Ohkuma, S Suzuki, S Yagihashi.   

Abstract

SUMMARY: Twelve cases of ruptured cerebral aneurysm were treated in acute stage with interlocking detachable coils (IDC, Target Therapeutics, Fremont, California) and the outcome was assessed. IDCs were placed intra-aneurysm for intraaneurysmal occlusion, or intra-artery for proximal occlusion. CASES: age 36-84 (mean; 60) y.o., 11 females and 1 male; 1, 5, 4 and 2 patients were categorised (Hunt and Hess) as grades 1, 2, 3 and 4 respectively. An intra-aneurysmal occlusion in ten cases and a proximal occlusion in two were performed on day 1-11 (mean 4). On angiograms and CT findings, the ruptured point seemed to have occluded in all cases. The occlusion rate was 100% in five cases, 95% in two, 90% in three, 80% in one, and less than 50% in one. There were two cases of technical complication, one a coil migration and the other an aneurysmal perforation with IDC. Their Glasgow Outcome Scale six months after embolisation was graded as good recovery in four cases, moderately disabled state in two, severely disabled state in one, and dead in five. Follow-up angiograms taken four to six months after embolisation showed an intra-aneurysmal coil compaction in five cases. Two of these were treated by a second embolisation or by neck clipping followed by aneurysmal resection, but another two were observed without any treatment and the last one died of rebleeding. Histological examination of the resected embolised aneurysm revealed slight organization around coils but no endothelialisation over the aneurysmal orifice. In our experience, coil embolisation with IDC for acute ruptured aneurysm is a promising means of preventing rerupture during subacute stage.

Entities:  

Year:  2001        PMID: 20678372     DOI: 10.1177/159101999700300106

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  6 in total

1.  The Underlying Mechanisms of Endovascular Exclusion of Intracranial Aneurysms by Coils. How Important is Electrothrombosis?

Authors:  H Henkes; S Brew; E Miloslavski; S Fischer; I Tavrovski; D Kühne
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

2.  Fibered electrolytically detachable platinum coils used for the endovascular treatment of intracranial aneurysms. Initial experiences and mid-term results in 474 aneurysms.

Authors:  T Liebig; H Henkes; S Fischer; W Weber; E Miloslavski; W Mariushi; S Brew; D Kühne
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

3.  Ex vivo study of the physical effect of coils on pressure and flow dynamics in experimental aneurysms.

Authors:  H G Boecher-Schwarz; K Ringel; L Kopacz; A Heimann; O Kempski
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

4.  Role of electrothrombosis in aneurysm treatment with Guglielmi detachable coils: an in vitro scanning electron microscopic study.

Authors:  R Padolecchia; G Guglielmi; M Puglioli; M Castagna; V Nardini; P L Collavoli; G Guidetti; M Dazzi; V Zucchi; P Narducci
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

5.  Endovascular Treatment of Berry Intracranial Aneurysms Using a New Detachable Coil System. (DCS ((R)) - Detachable Coil System Cook).

Authors:  A Tournade; C Riquelme; M Musacchio; F Mont'alverne
Journal:  Interv Neuroradiol       Date:  2001-07-15       Impact factor: 1.610

Review 6.  Histopathologic findings in human cerebral aneurysms embolized with platinum coils: report of two cases and review of the literature.

Authors:  Shoichiro Ishihara; Michel E Mawad; Kentaro Ogata; Chihiro Suzuki; Nobusuke Tsuzuki; Hiroshi Katoh; Akira Ohnuki; Takahito Miyazawa; Hiroshi Nawashiro; Tatsumi Kaji; Katsuji Shima
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.